Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ABOS

Acumen Pharmaceuticals, Inc.

CIK 0001576885 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.16
↓ 0.03 (-0.94%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap
$228.52M
P/E Ratio
-2.18
EPS
-2.00
Dividend Yield
Not covered
52W Position
82%
Beta
1.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.99
P/S
Not covered
EV/Revenue
Not covered
ROE
-183.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 82%
$1.21$3.60

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$121.33M
Total Assets
$122.83M
Free Cash Flow
–

Recent news